123 related articles for article (PubMed ID: 32162845)
21. Inhibition of glutamine metabolism increases sensitivity to plasma-activated medium-induced cytotoxicity.
Tanaka S; Hayashi S; Otsuka T; Kamiya T; Ishikawa K; Hara H
Free Radic Res; 2024 Mar; 58(3):170-179. PubMed ID: 38511644
[TBL] [Abstract][Full Text] [Related]
22. Radiation-induced exosomes promote oral squamous cell carcinoma progression via enhancing SLC1A5-glutamine metabolism.
Yang R; Zhang S; Wang L; Chen Y; Chen X; Xia J; Ren X; Cheng B; Chen X
J Oral Pathol Med; 2024 May; ():. PubMed ID: 38802300
[TBL] [Abstract][Full Text] [Related]
23. Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle.
Wang X; Yuan L; Lu B; Lin D; Xu X
Exp Ther Med; 2023 Dec; 26(6):574. PubMed ID: 38023359
[TBL] [Abstract][Full Text] [Related]
24. ASCT2 is the primary serine transporter in cancer cells.
Conger KO; Chidley C; Ozgurses ME; Zhao H; Kim Y; Semina SE; Burns P; Rawat V; Sheldon R; Ben-Sahra I; Frasor J; Sorger PK; DeNicola GM; Coloff JL
bioRxiv; 2023 Oct; ():. PubMed ID: 37873453
[TBL] [Abstract][Full Text] [Related]
25. Alanine serine cysteine transporter (ASCT) substrate binding site properties probed with hydroxyhomoserine esters.
Ndaru E; Zielewicz L; Shi Y; Hutchinson K; Garibsingh RA; Schlessinger A; Grewer C
J Phys Org Chem; 2022 Nov; 35(11):. PubMed ID: 36568026
[TBL] [Abstract][Full Text] [Related]
26. RNA binding motif protein 45-mediated phosphorylation enhances protein stability of ASCT2 to promote hepatocellular carcinoma progression.
Du D; Qin M; Shi L; Liu C; Jiang J; Liao Z; Wang H; Zhang Z; Sun L; Fan H; Liu Z; Yu H; Li H; Peng J; Yuan S; Yang M; Xiong J
Oncogene; 2023 Oct; 42(42):3127-3141. PubMed ID: 37658192
[TBL] [Abstract][Full Text] [Related]
27. Loss of vascular endothelial glutaminase inhibits tumor growth and metastasis, and increases sensitivity to chemotherapy.
Ngwa VM; Edwards DN; Hwang Y; Karno B; Wang X; Yan C; Richmond A; Brantley-Sieders DM; Chen J
Cancer Res Commun; 2022 Jul; 2(7):694-705. PubMed ID: 36381236
[TBL] [Abstract][Full Text] [Related]
28. Peroxiredoxin 1 regulates crosstalk between pyroptosis and autophagy in oral squamous cell carcinoma leading to a potential pro-survival.
Ye M; Liu T; Liu S; Tang R; Liu H; Zhang F; Luo S; Li M
Cell Death Discov; 2023 Nov; 9(1):425. PubMed ID: 38007535
[TBL] [Abstract][Full Text] [Related]
29. Targeted down-regulation of SRSF1 exerts anti-cancer activity in OSCC through impairing lysosomal function and autophagy.
Qu Y; He Y; Wang Y; Han Z; Qin L
iScience; 2023 Dec; 26(12):108330. PubMed ID: 38025785
[TBL] [Abstract][Full Text] [Related]
30. Glutamine addiction in tumor cell: oncogene regulation and clinical treatment.
Li X; Peng X; Li Y; Wei S; He G; Liu J; Li X; Yang S; Li D; Lin W; Fang J; Yang L; Li H
Cell Commun Signal; 2024 Jan; 22(1):12. PubMed ID: 38172980
[TBL] [Abstract][Full Text] [Related]
31. Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP-ALL cell survival and a potential therapeutic target.
Taurino G; Dander E; Chiu M; Pozzi G; Maccari C; Starace R; Silvestri D; Griffini E; Bianchi MG; Carubbi C; Andreoli R; Mirandola P; Valsecchi MG; Rizzari C; D'Amico G; Bussolati O
Br J Haematol; 2024 May; ():. PubMed ID: 38736325
[TBL] [Abstract][Full Text] [Related]
32. Dual Starvations Induce Pyroptosis for Orthotopic Pancreatic Cancer Therapy through Simultaneous Deprivation of Glucose and Glutamine.
Wang X; Ding B; Liu W; Qi L; Li J; Zheng X; Song Y; Li Q; Wu J; Zhang M; Chen H; Wang Y; Li Y; Sun B; Ma P
J Am Chem Soc; 2024 May; ():. PubMed ID: 38776361
[TBL] [Abstract][Full Text] [Related]
33. Reclaiming the Balance: Blocking Glutamine Uptake to Restrain Pulmonary Fibrosis.
Liu G; Summer R
Am J Respir Cell Mol Biol; 2023 Oct; 69(4):378-379. PubMed ID: 37463521
[No Abstract] [Full Text] [Related]
34. Design strategies and recent development of bioactive modulators for glutamine transporters.
Cheng X; Wang Y; Gong G; Shen P; Li Z; Bian J
Drug Discov Today; 2024 Feb; 29(2):103880. PubMed ID: 38216118
[TBL] [Abstract][Full Text] [Related]
35. Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities.
Ling Z; Cheng B; Tao X
Int J Cancer; 2021 Apr; 148(7):1548-1561. PubMed ID: 33091960
[TBL] [Abstract][Full Text] [Related]
36. Target the human Alanine/Serine/Cysteine Transporter 2(ASCT2): Achievement and Future for Novel Cancer Therapy.
Jiang H; Zhang N; Tang T; Feng F; Sun H; Qu W
Pharmacol Res; 2020 Aug; 158():104844. PubMed ID: 32438035
[TBL] [Abstract][Full Text] [Related]
37. A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer.
Jin H; Wang S; Zaal EA; Wang C; Wu H; Bosma A; Jochems F; Isima N; Jin G; Lieftink C; Beijersbergen R; Berkers CR; Qin W; Bernards R
Elife; 2020 Oct; 9():. PubMed ID: 33016874
[TBL] [Abstract][Full Text] [Related]
38. NNK-mediated upregulation of DEPDC1 stimulates the progression of oral squamous cell carcinoma by inhibiting CYP27B1 expression.
Guo J; Zhou S; Huang P; Xu S; Zhang G; He H; Zeng Y; Xu CX; Kim H; Tan Y
Am J Cancer Res; 2020; 10(6):1745-1760. PubMed ID: 32642287
[TBL] [Abstract][Full Text] [Related]
39. The role of the glutamine transporter ASCT2 in antineoplastic therapy.
Teixeira E; Silva C; Martel F
Cancer Chemother Pharmacol; 2021 Apr; 87(4):447-464. PubMed ID: 33464409
[TBL] [Abstract][Full Text] [Related]
40. LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression.
Dias F; Almeida C; Teixeira AL; Morais M; Medeiros R
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33669301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
